4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-26-057366
Chief Financial Officer acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Steinhart Richard I · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 1 in the form | +9,000 | 15,645 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-01 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −9,000 | 0 | D |
Loading xslF345X06/tm2613630-3_4seq1.xml…